Mutations in the

Anti-Bacterial Agents / pharmacology Bacterial Proteins / genetics Biofilms Genome-Wide Association Study Humans Methicillin / pharmacology Methicillin-Resistant Staphylococcus aureus / genetics Microbial Sensitivity Tests Mutation Oxacillin / pharmacology Penicillin-Binding Proteins / genetics Staphylococcal Infections Staphylococcus aureus / genetics beta-Lactam Resistance / genetics beta-Lactams / pharmacology
GWAS MRSA c-di-AMP gdpP mutations penicillin-binding proteins

Journal

Microbial genomics
ISSN: 2057-5858
Titre abrégé: Microb Genom
Pays: England
ID NLM: 101671820

Informations de publication

Date de publication:
09 2021
Historique:
entrez: 6 9 2021
pubmed: 7 9 2021
medline: 27 1 2022
Statut: ppublish

Résumé

In

Identifiants

DOI: 10.1099/mgen.0.000623 PMID: 34486969 PMC: PMC8715439
pubmed: 34486969
doi: 10.1099/mgen.0.000623
pmc: PMC8715439
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
Penicillin-Binding Proteins 0
beta-Lactams 0
Methicillin Q91FH1328A
Oxacillin UH95VD7V76

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Clin Microbiol. 2003 Dec;41(12):5442-8
pubmed: 14662923
PLoS One. 2014 Sep 24;9(9):e107937
pubmed: 25251407
Clin Microbiol Infect. 2010 Jul;16(7):979-85
pubmed: 20880412
Trends Microbiol. 2018 Mar;26(3):175-185
pubmed: 28965724
PLoS One. 2011;6(9):e24360
pubmed: 21931689
Emerg Infect Dis. 2018 Feb;24(2):242-248
pubmed: 29350135
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Curr Opin Microbiol. 2015 Jun;25:17-24
pubmed: 25835153
J Bacteriol. 2015 Jul 20;198(1):98-110
pubmed: 26195599
Antimicrob Agents Chemother. 2017 May 24;61(6):
pubmed: 28373193
Antimicrob Agents Chemother. 2018 Jun 26;62(7):
pubmed: 29661881
J Med Microbiol. 2017 Oct;66(10):1367-1373
pubmed: 28893360
J Clin Microbiol. 2000 Mar;38(3):1008-15
pubmed: 10698988
Int J Med Microbiol. 2014 Oct;304(7):794-804
pubmed: 25034857
Toxins (Basel). 2019 Sep 13;11(9):
pubmed: 31540335
Genome Med. 2014 Nov 15;6(11):101
pubmed: 25484920
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
J Clin Microbiol. 2014 Aug;52(8):3114-7
pubmed: 24850355
PLoS Genet. 2018 Nov 12;14(11):e1007758
pubmed: 30419019
J Clin Microbiol. 2008 Feb;46(2):574-81
pubmed: 18032612
Front Microbiol. 2018 Feb 23;9:322
pubmed: 29527200
J Antimicrob Chemother. 2014 Mar;69(3):594-7
pubmed: 24216768
J Biol Chem. 2015 Feb 27;290(9):5826-39
pubmed: 25575594
Genome Biol. 2016 Nov 25;17(1):238
pubmed: 27887642
Nucleic Acids Res. 2019 Jan 8;47(D1):D351-D360
pubmed: 30398656
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Acta Derm Venereol. 2006;86(3):230-4
pubmed: 16710581
Pediatr Pulmonol. 2011 May;46(5):489-96
pubmed: 21337531
Front Microbiol. 2020 Jan 30;10:3119
pubmed: 32082269
Heliyon. 2020 Jun 21;6(6):e04070
pubmed: 32613099
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28807923
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W452-7
pubmed: 22689647
Microb Drug Resist. 2005 Spring;11(1):78-81
pubmed: 15770100
Curr Opin Microbiol. 2018 Apr;42:62-70
pubmed: 29125939
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
Antimicrob Agents Chemother. 2012 Jan;56(1):579-81
pubmed: 21986827
J Med Microbiol. 2006 Dec;55(Pt 12):1675-1683
pubmed: 17108271
Genome Biol. 2014 Mar 03;15(3):R46
pubmed: 24580807
J Clin Microbiol. 2014 Jul;52(7):2365-70
pubmed: 24759713
J Clin Microbiol. 2009 Mar;47(3):859-61
pubmed: 19116360
PLoS Pathog. 2011 Sep;7(9):e1002217
pubmed: 21909268
Front Cell Infect Microbiol. 2015 Jan 28;5:1
pubmed: 25674541
J Bacteriol. 2008 Aug;190(15):5178-89
pubmed: 18502872
Mol Microbiol. 2016 Mar;99(5):945-59
pubmed: 26564551
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
Nat Rev Genet. 2017 Jan;18(1):41-50
pubmed: 27840430
Eur J Clin Microbiol Infect Dis. 1999 Nov;18(11):834-6
pubmed: 10614964
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
J Antimicrob Chemother. 2019 May 1;74(5):1182-1191
pubmed: 30759229
J Clin Microbiol. 2016 Nov;54(11):2774-2785
pubmed: 27605711
J Bacteriol. 2003 Jun;185(11):3307-16
pubmed: 12754228
J Clin Microbiol. 2012 Oct;50(10):3186-92
pubmed: 22814464
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5969-E5978
pubmed: 28674000
Sci Signal. 2016 Aug 16;9(441):ra81
pubmed: 27531650
Front Microbiol. 2021 Feb 15;12:639660
pubmed: 33658988
Antimicrob Agents Chemother. 2010 Nov;54(11):4900-2
pubmed: 20805396
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Nov;55(11-12):1377-86
pubmed: 23114436
Annu Rev Biochem. 2015;84:577-601
pubmed: 26034890
J Bacteriol. 2005 Mar;187(5):1815-24
pubmed: 15716453
Antimicrob Agents Chemother. 1995 Jan;39(1):103-6
pubmed: 7695289
PLoS One. 2018 Jul 3;13(7):e0199707
pubmed: 29969476
J Clin Microbiol. 1986 May;23(5):832-9
pubmed: 3011847
mBio. 2020 Dec 8;11(6):
pubmed: 33293382
J Clin Microbiol. 2018 May 25;56(6):
pubmed: 29643197
PLoS One. 2013 Aug 27;8(8):e73512
pubmed: 24013956
Mol Cell Proteomics. 2018 Dec;17(12):2412-2433
pubmed: 30201737
Microb Drug Resist. 2021 May;27(5):590-595
pubmed: 32991274
Microbiology (Reading). 2011 Dec;157(Pt 12):3314-3323
pubmed: 21921101
mBio. 2015 May 26;6(3):e00308-15
pubmed: 26015493

Auteurs

Anna Sommer (A)

Department of Infectious Diseases, Nosocomial Pathogens and Antibiotic Resistances, Robert Koch Institute, Wernigerode, Germany.

Stephan Fuchs (S)

Methodology and Research Infrastructure, Bioinformatics, Robert Koch Institute, Berlin, Germany.

Franziska Layer (F)

Department of Infectious Diseases, Nosocomial Pathogens and Antibiotic Resistances, Robert Koch Institute, Wernigerode, Germany.

Christoph Schaudinn (C)

Centre for Biological Threats and Special Pathogens, Advanced Light and Electron Microscopy, Robert Koch Institute, Berlin, Germany.

Robert E Weber (RE)

Department of Infectious Diseases, Nosocomial Pathogens and Antibiotic Resistances, Robert Koch Institute, Wernigerode, Germany.

Hugues Richard (H)

Methodology and Research Infrastructure, Bioinformatics, Robert Koch Institute, Berlin, Germany.

Mareike B Erdmann (MB)

Department of Infectious Diseases, Nosocomial Pathogens and Antibiotic Resistances, Robert Koch Institute, Wernigerode, Germany.

Michael Laue (M)

Centre for Biological Threats and Special Pathogens, Advanced Light and Electron Microscopy, Robert Koch Institute, Berlin, Germany.

Christopher F Schuster (CF)

Department of Infectious Diseases, Nosocomial Pathogens and Antibiotic Resistances, Robert Koch Institute, Wernigerode, Germany.

Guido Werner (G)

Department of Infectious Diseases, Nosocomial Pathogens and Antibiotic Resistances, Robert Koch Institute, Wernigerode, Germany.

Birgit Strommenger (B)

Department of Infectious Diseases, Nosocomial Pathogens and Antibiotic Resistances, Robert Koch Institute, Wernigerode, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Mutations in the
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines bactériennes › Mutations in the
questionsmedicales.fr › Phénomènes microbiologiques › Biofilms › Mutations in the
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Épidémiologie moléculaire › Étude d'association pangénomique › Mutations in the
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Mutations in the
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Pénicillines › Méticilline › Mutations in the
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Cocci à Gram positif › Staphylococcaceae › Staphylococcus › Staphylococcus aureus › Staphylococcus aureus résistant à la méticilline › Mutations in the
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Mutations in the
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Mutations in the
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Pénicillines › Oxacilline › Mutations in the
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines bactériennes › Protéines de liaison aux pénicillines › Mutations in the
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Infections à staphylocoques › Mutations in the
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Cocci à Gram positif › Staphylococcaceae › Staphylococcus › Staphylococcus aureus › Mutations in the
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Résistance aux bêta-lactamines › Mutations in the
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Mutations in the